Cover Image
市場調查報告書

核酸增幅檢查市場分析:各用途(感染疾病,癌症,個人化醫療,遺傳基因),各技術(標的放大,探針放大,信號放大),市場區隔預測

Nucleic Acid Amplification Testing Market Analysis By Application (Infectious Diseases, Cancer, Personalized Medicine, Genetic), By Technique (target amplification, probe amplification, & signal amplification), And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 478637
出版日期 內容資訊 英文 90 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
核酸增幅檢查市場分析:各用途(感染疾病,癌症,個人化醫療,遺傳基因),各技術(標的放大,探針放大,信號放大),市場區隔預測 Nucleic Acid Amplification Testing Market Analysis By Application (Infectious Diseases, Cancer, Personalized Medicine, Genetic), By Technique (target amplification, probe amplification, & signal amplification), And Segment Forecasts, 2014 - 2025
出版日期: 2017年02月10日 內容資訊: 英文 90 Pages
簡介

本報告提供全球核酸增幅檢查市場相關調查,彙整市場趨勢,各用途,各技術,各地區趨勢,打入市場的主要企業簡介等資料。

第1章 調查方法

第2章 摘要整理

第3章 市場變數,趨勢,範圍

  • 市場區隔和範圍
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • 滲透與成長預測製圖
  • SWOT分析
  • 產業分析:波特五力分析

第4章 各用途預測與趨勢分析

  • 各用途趨勢分析及市場佔有率
  • 感染疾病
  • 癌症
  • 個人化醫療
  • 遺傳基因疾病及粒腺體疾病

第5章 各技術預測與趨勢分析

  • 各技術趨勢分析
  • 標的放大系統
  • 探針放大系統
  • 信號放大系統

第6章 各地區預測與趨勢分析

  • 市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭環境

  • 策略架構
  • 市場進入類別
  • 企業簡介
目錄
Product Code: GVR-1-68038-388-1

The global nucleic acid amplification test (NAAT) market is expected to reach USD 4.4 Billion by 2025, according to a new report by Grand View Research, Inc. Nucleic acid amplification testing is gaining preference over traditional diagnostic techniques because of its high efficiency and accuracy. In addition, the potential application of these tests in various life-threatening diseases, including several types of cancer, is attracting a large amount of investment for the purpose of R&D. Increasing number of ongoing studies are expected to ensure higher growth rate in the later part of the forecast period.

These tests are currently being used extensively for screening and diagnosis of a wide range of infectious diseases. Along with known infectious diseases, management of epidemics of new diseases has caused a sudden surge in the demand for advanced diagnostic tests. NAAT is currently the most advanced and efficient diagnostic method, which extensively uses technology that helps in reducing procedural time and consumption of reagents.

Further Key Findings from the Study Suggest:

  • The market study suggests that infectious diseases segment captured the largest revenue share in 2015 owing to the high demand for effective screening methods for management of these diseases
  • Cancer is expected to exhibit the fastest growth during the forecast period due to the rising number of studies to develop tests for early detection of various cancer types
  • Expanding applications prenatal screening and for the detection of mitochondrial disorders is expected to boost the demand for NAAT
  • High usage of the PCR technique in NAT is driving the growth of the segment and is expected to capture significant revenue share in the near future
  • North America dominated the space in 2015 with U.S. capturing the largest share
  • Evolution of biotechnology sector in the Asia Pacific, along with the favorable government initiatives, Asia Pacific is expected to show the fastest growth rate during the forecast period
  • A few of the major players in the market are F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Becton, Dickinson and Company; Novartis AG; Beckman Coulter, Inc.; bioMerieux SA; Abbott Laboratories; Siemens Healthineers, and Illumina, Inc.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis
  • 1.3 Approaches for Market Estimation
    • 1.3.1 Approach 1: Demand Analysis& Bottom up Approach
    • 1.3.2 Approach 2: Top-down market estimation
    • 1.3.3 Approach 3: Commodity flow and bottom-up market estimation
    • 1.3.4 Approach 4: KoL perspective-based market sizing

Chapter 2 Executive Summary

  • 2.1 Market Segmentation& Scope

Chapter 3 Nucleic Acid Amplification Testing Market Variables, Trends & Scope

  • 3.1 Market Segmentation& Scope
    • 3.1.1 Market driver analysis
    • 3.1.2 Market restraint analysis
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Nucleic Acid Amplification Testing Systems-SWOT Analysis, by Factor (political & legal, economic and technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4 Nucleic Acid Amplification Testing: Application Estimates & Trend Analysis

  • 4.1 Nucleic Acid Amplification Testing Market: Application Movement Analysis
  • 4.2 Infectious Disease
    • 4.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 4.2.2 Virus
      • 4.2.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 4.2.3 Bacteria
      • 4.2.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 4.2.4 Others
      • 4.2.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 4.3 Cancer
    • 4.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 4.4 Personalized Medicine
    • 4.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 4.5 Genetic and Mitochondrial Disorders
    • 4.5.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)

Chapter 5 Nucleic Acid Amplification Testing: Technique Estimates & Trend Analysis

  • 5.1 Nucleic Acid Amplification Testing Market: Technique Movement Analysis
  • 5.2 Target Amplification Systems
    • 5.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 5.3 Probe Amplification Systems
    • 5.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 5.4 Signal Amplification Systems
    • 5.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)

Chapter 6 Nucleic Acid Amplification Testing: Regional Estimates & Trend Analysis, by Application, and Techniques

  • 6.1 Nucleic Acid Amplification Testing: Region Movement Analysis
  • 6.2 North America
    • 6.2.1 Market Estimates and Forecast, 2014 - 2024 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe nucleic acid amplification testing market, 2014 - 2025 (USD Million)
    • 6.3.2 U.K.
      • 6.3.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.4.2 China
      • 6.4.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.4.3 India
      • 6.4.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 6.6 Middle East and Africa (MEA)
    • 6.6.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Strategy Framework
  • 7.2 Market Participation Categorization
  • 7.3 Company Profiles
    • 7.3.1 Becton, Dickinson and Company
      • 7.3.1.1 Company overview
      • 7.3.1.2 Financial performance
      • 7.3.1.3 Product benchmarking
      • 7.3.1.4 Strategic initiatives
    • 7.3.2 Hoffmann-La Roche Ltd
      • 7.3.2.1 Company overview
      • 7.3.2.2 Financial performance
      • 7.3.2.3 Product benchmarking
      • 7.3.2.4 Strategic initiatives
    • 7.3.3 Siemens Healthcare GmbH
      • 7.3.3.1 Company overview
      • 7.3.3.2 Financial performance
      • 7.3.3.3 Product benchmarking
      • 7.3.3.4 Strategic initiatives
    • 7.3.4 Bio-Rad Laboratories, Inc.
      • 7.3.4.1 Company overview
      • 7.3.4.2 Financial performance
      • 7.3.4.3 Product benchmarking
      • 7.3.4.4 Strategic initiatives
    • 7.3.5 bioMerieux SA
      • 7.3.5.1 Company overview
      • 7.3.5.2 Financial performance
      • 7.3.5.3 Product benchmarking
      • 7.3.5.4 Strategic initiatives
    • 7.3.6 Illumina, Inc.
      • 7.3.6.1 Company overview
      • 7.3.6.2 Financial performance
      • 7.3.6.3 Product benchmarking
      • 7.3.6.4 Strategic initiatives
    • 7.3.7 Grifols SA
      • 7.3.7.1 Company overview
      • 7.3.7.2 Financial performance
      • 7.3.7.3 Product benchmarking
      • 7.3.7.4 Strategic initiatives
    • 7.3.8 Beckman Coulter, Inc.
      • 7.3.8.1 Company overview
      • 7.3.8.2 Financial performance
      • 7.3.8.3 Product benchmarking
      • 7.3.8.4 Strategic initiatives
    • 7.3.9 Abbott
      • 7.3.9.1 Company overview
      • 7.3.9.2 Financial performance
      • 7.3.9.3 Product benchmarking
      • 7.3.9.4 Strategic initiatives
    • 7.3.10 Hologic, Inc.
      • 7.3.10.1 Company overview
      • 7.3.10.2 Financial performance
      • 7.3.10.3 Product benchmarking
      • 7.3.10.4 Strategic initiatives

List of Tables

  • TABLE 1: North America nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 2: North America infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 3: North America nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 4: U.S. nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 5: U.S. infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 6: U.S. nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 7: Canada nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 8: Canada infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 9: Canada nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 10: Europe nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 11: Europe infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 12: Europe nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 13: U.K. nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 14: U.K. infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 15: U.K. nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 16: Germany nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 17: Germany infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 18: Germany nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 19: Asia Pacific nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 20: Asia Pacific infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 21: Asia Pacific nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 22: China nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 23: China infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 24: China nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 25: India nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 26: India infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 27: India nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 28: Latin America nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 29: Latin America infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 30: Latin America nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 31: Brazil nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 32: Brazil infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 33: Brazil nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 34: Mexico nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 35: Mexico infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 36: Mexico nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 37: MEA nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 38: MEA infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 39: MEA nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 40: South Africa nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 41: South Africa infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 42: South Africa nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1: Market research process
  • FIG. 2: Information procurement
  • FIG. 3: Primary research pattern
  • FIG. 4: Market research approaches
  • FIG. 5: Value chain based sizing & forecasting
  • FIG. 6: QFD modeling for market share assessment
  • FIG. 7: Market summary (USD Million)
  • FIG. 8: Market trends & outlook
  • FIG. 9: Market segmentation & scope
  • FIG. 10: Market driver relevance analysis (Current & future impact)
  • FIG. 11: Market restraint relevance analysis (Current & future impact)
  • FIG. 12: Penetration & growth prospect mapping
  • FIG. 13: SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 14: Porter's Five Forces Analysis
  • FIG. 15: Nucleic acid amplification market: Application outlook key takeaways
  • FIG. 16: Nucleic acid amplification testing: Application movement analysis
  • FIG. 17: Infectious disease market, 2014 - 2025 (USD Million)
  • FIG. 18: Virus market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 19: Bacteria market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 20: Others market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 21: Cancer market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 22: Personalized medicine market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 23: Genetic and mitochondrial disorders market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 24: Nucleic acid amplification testing market technique outlook key takeaways
  • FIG. 25: Nucleic acid amplification testing: Technique movement analysis
  • FIG. 26: Target amplification systems market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 27: Probe amplification systems market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 28: Signal amplification systems market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 29: Regional market place: Key takeaways
  • FIG. 30: Nucleic acid amplification testing: Region movement analysis
  • FIG. 31: Strategy framework
  • FIG. 32: Participant categorization
Back to Top